Find patient medical information for Butorphanol nasal on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings ...

After a year plagued by recalls, Pfizer’s sterile injectables unit Hospira seems no closer to righting the ship over its glass-contamination woes. | After a year plagued by recalls, Pfizer’s ...

Hospira, a New York City-based Pfizer company, has recalled two lots of lidocaine and one lot of sodium bicarbonate due to potential glass particles.

Butorphanol has been associated with adverse behavioral and gastrointestinal tract effects in horses including ataxia, decreased borborygmi, and decreased defecation (14). To our knowledge, there are ...

Hospira has now petitioned for rehearing en banc, arguing that the court’s holding “calls into question the continuing viability of the Safe Harbor, particularly in the context of BPCIA ...

Hospira manufacturing problems are plaguing Pfizer two years after paying $15 billion for the company.

Two drug companies that use or repackage Hospira products launched secondary recalls in response to the drugmaker's June 15 recall of several injectable drugs.

In a recent hearing held in Amgen v. Hospira, the parties offered arguments on some novel issues relating to litigation under the BPCIA, ...

When Pfizer announced its $15 billion deal to buy sterile injectable specialist Hospira, execs said they had studied FDA concerns over Hospira manufacturing before pulling the trigger. But Hospira ...

Hospira will team up with Pfenex to exclusively develop and commercialize for worldwide sales its lead product candidate PF582, Pfenex's biosimilar candidate to Genentech's eye treatment Lucentis ...